Join
Live feed
·
INSIDERFilingvia Quantisnow
Karyopharm Therapeutics Inc. logo

Chief Accounting Officer Abate Kristin sold $38 worth of shares (19 units at $2.02), decreasing direct ownership by 0.08% to 23,782 units (SEC Form 4) to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KPTI (Karyopharm Therapeutics Inc.) and more on Quantisnow.